Diasome Pharmaceuticals, Inc. — Form D

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-30. The offering totals $15.0M, of which $9.0M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Marc Blair PennDirectorCleveland, OH
Devang KantesariaDirectorMiami, FL
Marc PennDirectorCleveland, OH
Peter Blair TollmanDirectorCleveland, OH
Robert GehoDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
Robert GehoPromoterCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Thomas McDonaldDirectorMiami, FL
Frank McCaneyDirectorPhiladelphia, PA
W. Blair GehoDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Richard Blair CarusoDirectorCleveland, OH
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-15D$15.6M$3.1M
2022-09-08D$19.1M$16.7M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2018-10-26D$18.6M$12.1M
2017-01-17D$8.0M$4.3M
2009-04-13D/A$13.4M$12.9M

More